Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pulmonary Disease Physician in San Antonio, TX
NPI: 1750309076Primary Practice Location
CHILDREN'S HOSPITAL OF SAN ANTONIO
333 N Santa Rosa St, San Antonio, TX
Primary Employer
Viemed
viemed.com
HQ Phone
Get M.D. Bela's Phone NumberMobile
Get M.D. Bela's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1994 - 2027
American Board of Internal Medicine
Critical Care Medicine
American Board of Internal Medicine
Pulmonary Disease
University of Texas Health Science Center at Houston
Fellowship • Pulmonary Disease and Critical Care Medicine
1996 - 1999
Residency • Internal Medicine
1993 - 1996
McGovern Medical School
med.uth.edu
Medical School
Until 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 34 | 60 |
Phase 1 study to evaluate the effect of the MEK inhibitor trametinib on cardiac repolarization in patients with solid tumours.
Authors: Drew Rasco, Kyriakos Papadopoulos, Amita Patnaik, Anthony Tolcher
Publication Date: 2016-05-20
Authors: Coope, C M, Verlander, N Q, Schneider, A, Hopkins, S, Welfare, W, Johnson, A P, Patel, B, Oliver, I
Journal: J Hosp Infect
Publication Date: 2018-03-09
Lead Sponsor: Humanetics Corporation
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), NYU Langone Health
Intervention / Treatment: DRUG: Placebo, DRUG: BIO 300 Oral Suspension
Lead Sponsor: Michael A. Matthay
Collaborators: United States Department of Defense, University of Minnesota, Oregon Health and Science University, Vanderbilt University Medical Center, The University of Texas Health Science Center, Houston, Harborview Injury Prevention and Research Center
Intervention / Treatment: BIOLOGICAL: Human Mesenchymal Stromal Cells, BIOLOGICAL: Cell Reconstitution Media
Lead Sponsor: Daniel Benjamin
Collaborators: National Center for Advancing Translational Sciences (NCATS), Biomedical Advanced Research and Development Authority
Intervention / Treatment: DRUG: Infliximab, DRUG: Remdesivir, DRUG: Abatacept, DRUG: cenicriviroc (closed to enrollment as of 3-Sep-2021)
